Literature DB >> 33743219

Risk of SARS-CoV-2 reinfection after natural infection.

Rosemary J Boyton1, Daniel M Altmann2.   

Abstract

Entities:  

Mesh:

Year:  2021        PMID: 33743219      PMCID: PMC7969128          DOI: 10.1016/S0140-6736(21)00662-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  13 in total

1.  Seasonal coronavirus protective immunity is short-lasting.

Authors:  Arthur W D Edridge; Joanna Kaczorowska; Alexis C R Hoste; Margreet Bakker; Michelle Klein; Katherine Loens; Maarten F Jebbink; Amy Matser; Cormac M Kinsella; Paloma Rueda; Margareta Ieven; Herman Goossens; Maria Prins; Patricia Sastre; Martin Deijs; Lia van der Hoek
Journal:  Nat Med       Date:  2020-09-14       Impact factor: 53.440

2.  Immunity to SARS-CoV-2 variants of concern.

Authors:  Daniel M Altmann; Rosemary J Boyton; Rupert Beale
Journal:  Science       Date:  2021-03-12       Impact factor: 47.728

3.  Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial.

Authors:  Pedro M Folegatti; Katie J Ewer; Parvinder K Aley; Brian Angus; Stephan Becker; Sandra Belij-Rammerstorfer; Duncan Bellamy; Sagida Bibi; Mustapha Bittaye; Elizabeth A Clutterbuck; Christina Dold; Saul N Faust; Adam Finn; Amy L Flaxman; Bassam Hallis; Paul Heath; Daniel Jenkin; Rajeka Lazarus; Rebecca Makinson; Angela M Minassian; Katrina M Pollock; Maheshi Ramasamy; Hannah Robinson; Matthew Snape; Richard Tarrant; Merryn Voysey; Catherine Green; Alexander D Douglas; Adrian V S Hill; Teresa Lambe; Sarah C Gilbert; Andrew J Pollard
Journal:  Lancet       Date:  2020-07-20       Impact factor: 79.321

4.  Recurrent COVID-19 including evidence of reinfection and enhanced severity in thirty Brazilian healthcare workers.

Authors:  Letícia Adrielle Dos Santos; Pedro Germano de Góis Filho; Ana Maria Fantini Silva; João Victor Gomes Santos; Douglas Siqueira Santos; Marília Marques Aquino; Rafaela Mota de Jesus; Maria Luiza Dória Almeida; João Santana da Silva; Daniel M Altmann; Rosemary J Boyton; Cliomar Alves Dos Santos; Camilla Natália Oliveira Santos; Juliana Cardoso Alves; Ianaline Lima Santos; Lucas Sousa Magalhães; Emilia M M A Belitardo; Danilo J P G Rocha; João P P Almeida; Luis G C Pacheco; Eric R G R Aguiar; Gubio Soares Campos; Silvia Inês Sardi; Rejane Hughes Carvalho; Amélia Ribeiro de Jesus; Karla Freire Rezende; Roque Pacheco de Almeida
Journal:  J Infect       Date:  2021-02-13       Impact factor: 6.072

5.  Assessment of the risk of SARS-CoV-2 reinfection in an intense re-exposure setting.

Authors:  Laith J Abu-Raddad; Hiam Chemaitelly; Joel A Malek; Ayeda A Ahmed; Yasmin A Mohamoud; Shameem Younuskunju; Houssein H Ayoub; Zaina Al Kanaani; Abdullatif Al Khal; Einas Al Kuwari; Adeel A Butt; Peter Coyle; Andrew Jeremijenko; Anvar Hassan Kaleeckal; Ali Nizar Latif; Riyazuddin Mohammad Shaik; Hanan F Abdul Rahim; Hadi M Yassine; Mohamed G Al Kuwari; Hamad Eid Al Romaihi; Mohamed H Al-Thani; Roberto Bertollini
Journal:  Clin Infect Dis       Date:  2020-12-14       Impact factor: 9.079

6.  Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals.

Authors:  Charlotte Manisty; Ashley D Otter; Thomas A Treibel; Áine McKnight; Daniel M Altmann; Timothy Brooks; Mahdad Noursadeghi; Rosemary J Boyton; Amanda Semper; James C Moon
Journal:  Lancet       Date:  2021-02-25       Impact factor: 79.321

7.  Convergent antibody responses to SARS-CoV-2 in convalescent individuals.

Authors:  Davide F Robbiani; Christian Gaebler; Frauke Muecksch; Julio C C Lorenzi; Zijun Wang; Alice Cho; Marianna Agudelo; Christopher O Barnes; Anna Gazumyan; Shlomo Finkin; Thomas Hägglöf; Thiago Y Oliveira; Charlotte Viant; Arlene Hurley; Hans-Heinrich Hoffmann; Katrina G Millard; Rhonda G Kost; Melissa Cipolla; Kristie Gordon; Filippo Bianchini; Spencer T Chen; Victor Ramos; Roshni Patel; Juan Dizon; Irina Shimeliovich; Pilar Mendoza; Harald Hartweger; Lilian Nogueira; Maggi Pack; Jill Horowitz; Fabian Schmidt; Yiska Weisblum; Eleftherios Michailidis; Alison W Ashbrook; Eric Waltari; John E Pak; Kathryn E Huey-Tubman; Nicholas Koranda; Pauline R Hoffman; Anthony P West; Charles M Rice; Theodora Hatziioannou; Pamela J Bjorkman; Paul D Bieniasz; Marina Caskey; Michel C Nussenzweig
Journal:  Nature       Date:  2020-06-18       Impact factor: 69.504

8.  Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates.

Authors:  Edward E Walsh; Robert W Frenck; Ann R Falsey; Nicholas Kitchin; Judith Absalon; Alejandra Gurtman; Stephen Lockhart; Kathleen Neuzil; Mark J Mulligan; Ruth Bailey; Kena A Swanson; Ping Li; Kenneth Koury; Warren Kalina; David Cooper; Camila Fontes-Garfias; Pei-Yong Shi; Özlem Türeci; Kristin R Tompkins; Kirsten E Lyke; Vanessa Raabe; Philip R Dormitzer; Kathrin U Jansen; Uğur Şahin; William C Gruber
Journal:  N Engl J Med       Date:  2020-10-14       Impact factor: 91.245

9.  Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infection.

Authors:  Catherine J Reynolds; Leo Swadling; Joseph M Gibbons; Corinna Pade; Melanie P Jensen; Mariana O Diniz; Nathalie M Schmidt; David K Butler; Oliver E Amin; Sasha N L Bailey; Sam M Murray; Franziska P Pieper; Stephen Taylor; Jessica Jones; Meleri Jones; Wing-Yiu Jason Lee; Joshua Rosenheim; Aneesh Chandran; George Joy; Cecilia Di Genova; Nigel Temperton; Jonathan Lambourne; Teresa Cutino-Moguel; Mervyn Andiapen; Marianna Fontana; Angelique Smit; Amanda Semper; Ben O'Brien; Benjamin Chain; Tim Brooks; Charlotte Manisty; Thomas Treibel; James C Moon; Mahdad Noursadeghi; Daniel M Altmann; Mala K Maini; Áine McKnight; Rosemary J Boyton
Journal:  Sci Immunol       Date:  2020-12-23
View more
  26 in total

1.  The EFIS vaccination task force expert report.

Authors:  Alexandros Sarantopoulos; Doug Brown; Ursula Wiedermann; Carmen Alvarez Dominguez; Christian Bogdan; İhsan Gürsel; Srđa Janković; Claude LeClerc; Massimo Locati; Anne Spurkland; Frederico Regateiro; Pierre Van Damme; Aurelija Žvirblienė; Felix M Wensveen
Journal:  Eur J Immunol       Date:  2021-05       Impact factor: 5.532

Review 2.  Structural and functional insights into the spike protein mutations of emerging SARS-CoV-2 variants.

Authors:  Deepali Gupta; Priyanka Sharma; Mandeep Singh; Mukesh Kumar; A S Ethayathulla; Punit Kaur
Journal:  Cell Mol Life Sci       Date:  2021-11-03       Impact factor: 9.261

3.  Risk of SARS-CoV-2 Reinfection 18 Months After Primary Infection: Population-Level Observational Study.

Authors:  Maria Elena Flacco; Graziella Soldato; Cecilia Acuti Martellucci; Giuseppe Di Martino; Roberto Carota; Antonio Caponetti; Lamberto Manzoli
Journal:  Front Public Health       Date:  2022-05-02

4.  Optimal control and cost-effectiveness analysis for a COVID-19 model with individual protection awareness.

Authors:  Yiran Yuan; Ning Li
Journal:  Physica A       Date:  2022-06-22       Impact factor: 3.778

Review 5.  COVID-19 false dichotomies and a comprehensive review of the evidence regarding public health, COVID-19 symptomatology, SARS-CoV-2 transmission, mask wearing, and reinfection.

Authors:  Kevin Escandón; Angela L Rasmussen; Isaac I Bogoch; Eleanor J Murray; Karina Escandón; Saskia V Popescu; Jason Kindrachuk
Journal:  BMC Infect Dis       Date:  2021-07-27       Impact factor: 3.090

6.  Reinfection With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Patients Undergoing Serial Laboratory Testing.

Authors:  Adnan I Qureshi; William I Baskett; Wei Huang; Iryna Lobanova; S Hasan Naqvi; Chi-Ren Shyu
Journal:  Clin Infect Dis       Date:  2022-01-29       Impact factor: 9.079

7.  SARS-Cov-2 immune waning and reinfection in care-home settings.

Authors:  Daniel M Altmann; Rosemary J Boyton
Journal:  Lancet Healthy Longev       Date:  2021-12-01

8.  COVID-19: Are reinfections a global health threat?

Authors:  Indrajit Banerjee; Jared Robinson; Brijesh Sathian
Journal:  Nepal J Epidemiol       Date:  2021-03-31

9.  SARS-CoV-2 antibody-positivity protects against reinfection for at least seven months with 95% efficacy.

Authors:  Laith J Abu-Raddad; Hiam Chemaitelly; Peter Coyle; Joel A Malek; Ayeda A Ahmed; Yasmin A Mohamoud; Shameem Younuskunju; Houssein H Ayoub; Zaina Al Kanaani; Einas Al Kuwari; Adeel A Butt; Andrew Jeremijenko; Anvar Hassan Kaleeckal; Ali Nizar Latif; Riyazuddin Mohammad Shaik; Hanan F Abdul Rahim; Gheyath K Nasrallah; Hadi M Yassine; Mohamed Ghaith Al Kuwari; Hamad Eid Al Romaihi; Mohamed H Al-Thani; Abdullatif Al Khal; Roberto Bertollini
Journal:  EClinicalMedicine       Date:  2021-04-28

10.  Ethnic differences in SARS-CoV-2 vaccine hesitancy in United Kingdom healthcare workers: Results from the UK-REACH prospective nationwide cohort study.

Authors:  Katherine Woolf; I Chris McManus; Christopher A Martin; Laura B Nellums; Anna L Guyatt; Carl Melbourne; Luke Bryant; Mayuri Gogoi; Fatimah Wobi; Amani Al-Oraibi; Osama Hassan; Amit Gupta; Catherine John; Martin D Tobin; Sue Carr; Sandra Simpson; Bindu Gregary; Avinash Aujayeb; Stephen Zingwe; Rubina Reza; Laura J Gray; Kamlesh Khunti; Manish Pareek
Journal:  Lancet Reg Health Eur       Date:  2021-07-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.